What do patients' efficacy and tolerability ratings of acute migraine medication tell us? Cross-sectional data from the DMKG Headache Registry.
Ruth RuscheweyhThomas DreslerStefanie FörderreutherCharly GaulGudrun GoßrauTim Patrick JürgensVictoria RuschilAndreas StraubeJörg ScheidtPublished in: Cephalalgia : an international journal of headache (2023)
In the present population recruited at specialized headache centers, patients rated triptans as more effective than non-opioid analgesics, naproxen as more effective than ibuprofen, and acute medication efficacy decreased with increasing headache frequency.Trial registration: The German Migraine and Headache Society Headache Registry is registered with the German Clinical Trials Register (DRKS 00021081).
Keyphrases
- clinical trial
- end stage renal disease
- ejection fraction
- newly diagnosed
- cross sectional
- healthcare
- liver failure
- peritoneal dialysis
- emergency department
- prognostic factors
- patient reported outcomes
- palliative care
- electronic health record
- intensive care unit
- patient reported
- mechanical ventilation
- pain management